| 1.28 0.35 (37.62%) | 09-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.68 |
1-year : | 1.96 |
| Resists | First : | 1.44 |
Second : | 1.68 |
| Pivot price | 1.08 |
|||
| Supports | First : | 1.12 |
Second : | 0.93 |
| MAs | MA(5) : | 1.06 |
MA(20) : | 1.07 |
| MA(100) : | 1.37  |
MA(250) : | 1.55 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 22.8 |
D(3) : | 17.3 |
| RSI | RSI(14): 62.9 |
|||
| 52-week | High : | 3.15 | Low : | 0.62 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AIFF ] has closed Bollinger Bands are 23.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.44 - 1.45 | 1.45 - 1.46 |
| Low: | 1 - 1.01 | 1.01 - 1.02 |
| Close: | 1.26 - 1.28 | 1.28 - 1.3 |
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Thu, 17 Sep 2026
The country’s largest brain-medicine clinic network plans to add Firefly’s AI brain-function tests - Stock Titan
Mon, 14 Sep 2026
Firefly Neuroscience, Inc. (NASDAQ: AIFF) Share Price, AIFF Stock News, AIFF Share Price & Updates - kalkine.ca
Sat, 05 Sep 2026
AIFF Should I Buy - Intellectia AI
Fri, 07 Aug 2026
Firefly Neuroscience (NASDAQ: AIFF) slashes authorized shares to 101M - Stock Titan
Sat, 25 Jul 2026
Firefly Neuroscience, Inc. Revenue Breakdown – NASDAQ:AIFF - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 16 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 28.1 (%) |
| Held by Institutions | 10.4 (%) |
| Shares Short | 477 (K) |
| Shares Short P.Month | 656 (K) |
| EPS | -0.51 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.93 |
| Profit Margin | 0 % |
| Operating Margin | -384.1 % |
| Return on Assets (ttm) | -34.9 % |
| Return on Equity (ttm) | -68.1 % |
| Qtrly Rev. Growth | 71.9 % |
| Gross Profit (p.s.) | 0.05 |
| Sales Per Share | 0.11 |
| EBITDA (p.s.) | -0.56 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -2.51 |
| PEG Ratio | 0 |
| Price to Book value | 1.36 |
| Price to Sales | 11.15 |
| Price to Cash Flow | -2.88 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|